Allogeneic natural killer cells

未知生产厂商

生成 AI 研报

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

STEM CELL-ENGINEERED INKT CELL-BASED OFF -THE-SHELF CELLULAR THERAPY
EP 3806869 A4申请人: UNIV CALIFORNIA优先权: 2018
CN
EP
US
WO
4 件公开
ENGINEERED OFF-THE-SHELF IMMUNE CELLS AND METHODS OF USE THEREOF
EP 3982979 A4申请人: UNIV CALIFORNIA优先权: 2019
CN
EP
US
WO
4 件公开
COMBATING COVID-19 USING ENGINEERED INKT CELLS
EP 4210717 A4申请人: THE REGENTS OF UNIV OF CALIFORNIA优先权: 2020
CN
EP
US
WO
4 件公开
CD52-DEFICIENT CELLS FOR ADOPTIVE CELL THERAPY
EP 3987008 A1申请人: CELYAD ONCOLOGY S A优先权: 2019
EP
US
WO
3 件公开
New Treatment of Sepsis
- US 20240148788 A1
  申请人: GUIZHOU SINORDA BIOTECHNOLOGY CO LTD优先权: 2021
  CN
  US
  2 件公开
- EP 4079312 A1
  申请人: GUIZHOU SINORDA BIOTECHNOLOGY CO LTD优先权: 2021
  EP
MODIFIED IMMUNE EFFECTOR CELLS WITH IMPROVED RESISTANCE TO NATURAL KILLER CELL-MEDIATED ALLOREJECTION
EP 4753741 A1申请人: BEAM THERAPEUTICS INC优先权: 2023
EP
WO
2 件公开
NOVEL INVARIANT NATURAL KILLER T CELLS AND T CELL ENGAGER COMPOSITIONS AND METHODS OF USE THEREOF
EP 4788350 A1申请人: MINK THERAPEUTICS INC优先权: 2023
EP
WO
2 件公开
ALLOGENEIC INVARIANT NATURAL KILLER T CELLS ADJUVANT FOR TREATMENT OF DISEASE AND RELATED METHODS
EP 4801521 A1申请人: MINK THERAPEUTICS INC优先权: 2023
EP
WO
2 件公开
Methods and compositions for allogeneic transplantation
US 7544355 B2申请人: UNI DEGLI STUDI PERUGIA优先权: 2003
US
2 件公开
Canine tumor cell and allogeneic dendritic cell fused vaccine and method for preparing the same
US 8778361 B2申请人: CHU REA-MIN优先权: 2009
US
2 件公开

药物

Allogeneic natural killer cells

专利

New Treatment of Sepsis